Tarik Issad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tarik Issad has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Nicolas Boute
Département de Biologie Cellulaire, Institut Cochin, INSERM, CNRS, Université Paris Descartes, 22 Rue Méchain, UMRCNRS 8104, INSERM U567, Paris, 75014, France
4 shared publications- Christophe Blanquart
Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d’Angers, CRCI2NA, F-44000 Nantes, France
2 shared publications Vladimir Zilberfarb
Unité d'Ecologie et de Physiologie du Système Digestif, INRA, Domaine de Vilvert, 78352 Jouy en Josas Cedex, France,1 Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France,2 Inserm, U567, Paris, France,3 Unité des Bactéries Lactiques et Pathogènes Opportunistes, INRA, Domaine de Vilvert, 78352 Jouy en Josas cedex, France4
2 shared publications- Alexandra Gruss
Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
1 shared publication Anne‐Françoise Burnol
Département d'Endocrinologie, Institut Cochin, INSERM, CNRS, Université Paris Descartes, 22 Rue Méchain, UMRCNRS 8104, INSERM U567, Paris, 75014, France
1 shared publicationCarmen Gonzalez-Yanes
1 shared publication
Latest Publications
- Open Access
- 15 April 2008
- Published by EDP Sciences in médecine/sciences
- Vol. 24 (4) , 369-371
Un nouveau mode de régulation de FoxO1 par O-glycosylation
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 15 April 2008
- Published by EDP Sciences in médecine/sciences
- Vol. 24 (4) , 369-371
Open AccessUn nouveau mode de régulation de FoxO1 par O-glycosylation
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 15 August 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (16) , 5300-5307
Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice
Leptin is an adipocyte-derived pleiotropic hormone that modulates a large number of physiological functions, including control of body weight and regulation of the immune system. In this work, we show that a recombinant strain of the food-grade lactic acid bacterium Lactococcus lactis (LL-lep) can produce and efficiently secrete human leptin. The secreted leptin is a fully biologically active hormone, as demonstrated by its capacity to stimulate a STAT3 reporter gene in HEK293 cells transfected with the Ob-Rb leptin receptor. The immunomodulatory activity of leptin-secreting L. lactis was evaluated in vivo by coexpression with the human papillomavirus type 16 E7 protein. In C57BL/6 mice immunized intranasally with a recombinant L. lactis strain coproducing leptin and E7 antigen, the adaptive immune response was significantly higher than in mice immunized with recombinant L. lactis producing only E7 antigen, demonstrating adjuvanticity of leptin. We then analyzed the effects of intranasally administered LL-lep in obese ob / ob mice. We observed that daily administration of LL-lep to these mice significantly reduced body weight gain and food intake. These results demonstrate that leptin can be produced and secreted in an active form by L. lactis and that leptin-producing L. lactis regulates in vivo antigen-specific immune responses, as well as body weight and food consumption.
- 15 August 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (16) , 5300-5307
Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice
Leptin is an adipocyte-derived pleiotropic hormone that modulates a large number of physiological functions, including control of body weight and regulation of the immune system. In this work, we show that a recombinant strain of the food-grade lactic acid bacterium Lactococcus lactis (LL-lep) can produce and efficiently secrete human leptin. The secreted leptin is a fully biologically active hormone, as demonstrated by its capacity to stimulate a STAT3 reporter gene in HEK293 cells transfected with the Ob-Rb leptin receptor. The immunomodulatory activity of leptin-secreting L. lactis was evaluated in vivo by coexpression with the human papillomavirus type 16 E7 protein. In C57BL/6 mice immunized intranasally with a recombinant L. lactis strain coproducing leptin and E7 antigen, the adaptive immune response was significantly higher than in mice immunized with recombinant L. lactis producing only E7 antigen, demonstrating adjuvanticity of leptin. We then analyzed the effects of intranasally administered LL-lep in obese ob / ob mice. We observed that daily administration of LL-lep to these mice significantly reduced body weight gain and food intake. These results demonstrate that leptin can be produced and secreted in an active form by L. lactis and that leptin-producing L. lactis regulates in vivo antigen-specific immune responses, as well as body weight and food consumption.
- 20 March 2007
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 11 (4) , 541-556
The use of bioluminescence resonance energy transfer for the study of therapeutic targets: application to tyrosine kinase receptors
During recent years, the bioluminescence resonance energy transfer (BRET) methodology has emerged as a powerful technique for the study of protein–protein interactions. This review focuses on recent work demonstrating the power of BRET for the study of tyrosine kinase receptors, using insulin and IGF-1 receptors as models. The authors show that BRET can be used to monitor ligand-induced conformational changes within homodimeric insulin and IGF-1 receptors, as well as heterodimeric insulin/IGF-1 hybrid receptors. BRET can also be used to study, in real time and in living cells, the interaction of tyrosine kinase receptors with cellular partners negatively or positively involved in the regulation of intracellular signalling (protein tyrosine phosphatases, molecular adaptors). In addition, BRET can be used to develop high-throughput screening assays for the search of molecules with therapeutic interest and could, therefore, constitute a valuable tool for laboratories involved in drug discovery.
- 20 March 2007
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 11 (4) , 541-556
The use of bioluminescence resonance energy transfer for the study of therapeutic targets: application to tyrosine kinase receptors
During recent years, the bioluminescence resonance energy transfer (BRET) methodology has emerged as a powerful technique for the study of protein–protein interactions. This review focuses on recent work demonstrating the power of BRET for the study of tyrosine kinase receptors, using insulin and IGF-1 receptors as models. The authors show that BRET can be used to monitor ligand-induced conformational changes within homodimeric insulin and IGF-1 receptors, as well as heterodimeric insulin/IGF-1 hybrid receptors. BRET can also be used to study, in real time and in living cells, the interaction of tyrosine kinase receptors with cellular partners negatively or positively involved in the regulation of intracellular signalling (protein tyrosine phosphatases, molecular adaptors). In addition, BRET can be used to develop high-throughput screening assays for the search of molecules with therapeutic interest and could, therefore, constitute a valuable tool for laboratories involved in drug discovery.
- Open Access
- 31 March 2006
- Published by Springer Nature in EMBO Reports
- Vol. 7 (5) , 512-518
Interaction with Grb14 results in site‐specific regulation of tyrosine phosphorylation of the insulin receptor
The dynamics of interaction of the insulin receptor (IR) with Grb14 was monitored, in real time, in living human embryonic kidney cells, using bioluminescence resonance energy transfer (BRET). We observed that insulin rapidly and dose‐dependently stimulated this interaction. We also observed that insulin‐induced BRET between the IR and protein tyrosine phosphatase 1B (PTP1B) was markedly reduced by Grb14, suggesting that Grb14 regulated this interaction in living cells. Using site‐specific antibodies against phosphorylated tyrosines of the IR, we showed that Grb14 protected the three tyrosines of the kinase loop from dephosphorylation by PTP1B, while favouring dephosphorylation of tyrosine 972. This resulted in decreased IRS‐1 binding to the IR and decreased activation of the extracellular signal‐regulated kinase pathway. Increased Grb14 expression in human liver‐derived HuH7 cells also seemed to specifically decrease the phosphorylation of Y972. Our work therefore suggests that Grb14 may regulate signalling through the IR by controlling its tyrosine dephosphorylation in a site‐specific manner.
- 31 March 2006
- Published by Springer Nature in EMBO Reports
- Vol. 7 (5) , 512-518
Open AccessInteraction with Grb14 results in site‐specific regulation of tyrosine phosphorylation of the insulin receptor
The dynamics of interaction of the insulin receptor (IR) with Grb14 was monitored, in real time, in living human embryonic kidney cells, using bioluminescence resonance energy transfer (BRET). We observed that insulin rapidly and dose‐dependently stimulated this interaction. We also observed that insulin‐induced BRET between the IR and protein tyrosine phosphatase 1B (PTP1B) was markedly reduced by Grb14, suggesting that Grb14 regulated this interaction in living cells. Using site‐specific antibodies against phosphorylated tyrosines of the IR, we showed that Grb14 protected the three tyrosines of the kinase loop from dephosphorylation by PTP1B, while favouring dephosphorylation of tyrosine 972. This resulted in decreased IRS‐1 binding to the IR and decreased activation of the extracellular signal‐regulated kinase pathway. Increased Grb14 expression in human liver‐derived HuH7 cells also seemed to specifically decrease the phosphorylation of Y972. Our work therefore suggests that Grb14 may regulate signalling through the IR by controlling its tyrosine dephosphorylation in a site‐specific manner.
- 1 April 2003
- Published by Elsevier in Diabetes & Metabolism
- Vol. 29 (2) , 111-117
Looking for an insulin pill? Use the BRET methodology!
- 1 April 2003
- Published by Elsevier in Diabetes & Metabolism
- Vol. 29 (2) , 111-117
Looking for an insulin pill? Use the BRET methodology!
- Open Access
- 14 February 2003
- Published by Springer Nature in EMBO Reports
- Vol. 4 (3) , 313-319
Dynamics of the interaction between the insulin receptor and protein tyrosine‐phosphatase 1B in living cells
The dynamics of the interaction of the insulin receptor with a substrate‐trapping mutant of protein‐tyrosine phosphatase 1B (PTP1B) were monitored in living human embryonic kidney cells using bioluminescence resonance energy transfer (BRET). Insulin dose‐dependently stimulates this interaction, which could be followed in real time for more than 30 minutes. The effect of insulin on the BRET signal could be detected at early time‐points (30 seconds), suggesting that in intact cells the tyrosine‐kinase activity of the insulin receptor is tightly controlled by PTP1B. Interestingly, the basal (insulin‐independent) interaction of the insulin receptor with PTP1B was much weaker with a soluble form of the tyrosine‐phosphatase than with the endoplasmic reticulum (ER)‐targeted form. Inhibition of insulin‐receptor processing using tunicamycin suggests that the basal interaction occurs during insulin‐receptor biosynthesis in the ER. Therefore, localization of PTP1B in this compartment might be important for the regulation of insulin receptors during their biosynthesis.
- 14 February 2003
- Published by Springer Nature in EMBO Reports
- Vol. 4 (3) , 313-319
Open AccessDynamics of the interaction between the insulin receptor and protein tyrosine‐phosphatase 1B in living cells
The dynamics of the interaction of the insulin receptor with a substrate‐trapping mutant of protein‐tyrosine phosphatase 1B (PTP1B) were monitored in living human embryonic kidney cells using bioluminescence resonance energy transfer (BRET). Insulin dose‐dependently stimulates this interaction, which could be followed in real time for more than 30 minutes. The effect of insulin on the BRET signal could be detected at early time‐points (30 seconds), suggesting that in intact cells the tyrosine‐kinase activity of the insulin receptor is tightly controlled by PTP1B. Interestingly, the basal (insulin‐independent) interaction of the insulin receptor with PTP1B was much weaker with a soluble form of the tyrosine‐phosphatase than with the endoplasmic reticulum (ER)‐targeted form. Inhibition of insulin‐receptor processing using tunicamycin suggests that the basal interaction occurs during insulin‐receptor biosynthesis in the ER. Therefore, localization of PTP1B in this compartment might be important for the regulation of insulin receptors during their biosynthesis.
- 1 November 2002
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 973 (1) , 120-123
The Activity of the Insulin Receptor Assessed by Bioluminescence Resonance Energy Transfer
Abstract:This work describes a new assay, based on the bioluminescence resonance energy transfer (BRET) methodology, to monitor the activation state of the insulin receptor.
- 1 November 2002
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 973 (1) , 120-123
The Activity of the Insulin Receptor Assessed by Bioluminescence Resonance Energy Transfer
Abstract:This work describes a new assay, based on the bioluminescence resonance energy transfer (BRET) methodology, to monitor the activation state of the insulin receptor.
- 12 July 2002
- Published by Elsevier in Biochemical Pharmacology
- Vol. 64 (5-6) , 813-817
A homogenous assay to monitor the activity of the insulin receptor using Bioluminescence Resonance Energy Transfer
- 12 July 2002
- Published by Elsevier in Biochemical Pharmacology
- Vol. 64 (5-6) , 813-817
A homogenous assay to monitor the activity of the insulin receptor using Bioluminescence Resonance Energy Transfer